Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: Induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity

Christof Scheid, Rosemary Young, R. H. McDermott, Lesley Fitzsimmons, J.H. Scarffe, Peter L. Stern

Cancer Immunology Immunotherapy · 1994 · 52 citations · 50 references

DOIFull text

Open access

Concepts

References

50